Company Profile
PluroGen Therapeutics, Inc.
Drug Delivery
Wound
Skin
503 Broadleaf Way
Charlottesville, VA 22911
USA
www.plurogen.com
|
Incorporated in 2005
1 Employees
|
Privately Held
|
|
This Year's Highlights
- The 2 most critical milestones have already been achieved, required for regulatory approval and product launch, of safety & efficacy, well proven through continued successful human use of the technology platform and one of the first two products
- Secured commitments for $1.2M in financing including Cato Bioventures investment
- Requested pre-IND meeting with FDA for September 2006
|
Anticipated Highlights
- Sign contract with our manufacturing partner
- Approval of orphan drug regulatory status for both of our 1st 2 products
- FDA concurrence with our IND plan for our 1st product
|
|
Corporate Mission
PluroGen? Therapeutics? Mission ?
? is to create novel, simple and advanced products to improve healing of complex wounds to benefit patients and provide caregivers with new cost-effective wound care options
PluroGen? Therapeutics? Vision ?
? is to be the premier developer and supplier of comprehensive therapeutic products for the optimum management and repair of injured tissue.
|
